Atopic Dermatitis | Pfizer Información Médica

Materiales de Congresos

La información de esta página es seleccionada de materiales de congresos, áreas terapéuticas y de enfermedades. No pretende servir como una descripción general completa de todos los contenidos mencionados

Volver al áreas de Enfermedades

Póster

Marjolein de Bruin-Weller, Stephan Weidinger, Melinda Gooderham, Andrew Pink, Jonathan Silverberg, Marco DiBonaventura, Urs Kerkmann, Irina Lazariciu, Claire Clibborn Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals

Ver Presentación

Presentación Oral

Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Using Treat-to-Target Goals

Ver Presentación

Póster

Jonathan I. Silverberg, Andrew Blauvelt, Eric L. Simpson, Jacob P. Thyssen, Pinaki Biswas, Claire Feeney, Ricardo Rojo, Herwig Koppensteiner, Erman Guler, Urs Kerkmann, Stephan Weidinger Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Identifying Patient Subgroups With Comparable Benefit From Continuous Versus Reduced Abrocitinib Maintenance Doses in JADE REGIMEN

Ver Presentación

Presentación Oral

Identifying Patient Subgroups With Comparable Benefit From Continuous Versus Reduced Abrocitinib Maintenance Doses in JADE REGIMEN

Ver Presentación

Póster

Jacob P. Thyssen, H. Chih-ho Hong, Marjolein de Bruin-Weller, Roland Aschoff, April W. Armstrong, Raj Chovatiya, Christian Vestergaard, Ricardo Rojo, Hernan Valdez, Fan Zhang, Ankur Bhambri, Daniela E. Myers, Kimberly Watson, Erman Guler, Claire Clibborn, Marco DiBonaventura Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Improvement in Patient-Reported Symptoms and Quality of Life With Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis Who Received Background Topical Therapy: Results of a 26-Week, Randomized, Head-to-Head Trial

Ver Presentación

Póster

Michael Ardern-Jones, Mahreen Ameen, Marjolein de Bruin-Weller, Eric Simpson, Wing Sin Chiu, Pinaki Biswas, Gary Chan, Christopher Koulias, Stephan Weidinger Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Long-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Who Had Failed or Were Intolerant to Oral Non-Steroidal Immunosuppressants: Pooled Analysis of JADE Clinical Trials

Ver Presentación

Póster

Kristian Reich, Fernando Valenzuela, H. Chih-ho Hong, Kilian Eyerich, Zakiya Pressley Rice, Ankur Bhambri, Erman Guler, Fan Zhang, Ricardo Rojo, Gary Chan, Claire Clibborn Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Onset and Depth of Response with Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Phase 3b JADE DARE Clinical Trial

Ver Presentación

Presentación Oral

Onset and Depth of Response with Abrocitinib Versus Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: Analysis of the Phase 3b JADE DARE Clinical Trial

Ver Presentación

Póster

Jashin J. Wu, H. Chih-ho Hong, Joseph F. Merola, David Gruben, Erman Guler, Claire Feeney, Ankur Bhambri, Daniela E. Myers, Marco DiBonaventura Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Predictors of Nonresponse to Dupilumab in Patients With Atopic Dermatitis: A Machine Learning Analysis of United States Health Records and Claims Data

Ver Presentación

Póster

Eric L. Simpson, Kristian Reich, Jonathan I. Silverberg, Adnan Nasir, Paulo Ricardo Criado, Pinaki Biswas, Herwig Koppensteiner, Dorothy Fan, Ricardo Rojo, Saleem A. Farooqui Diciembre 15, 2021 RAD December 2021 Dermatitis Atópica

Protocol for an Ongoing, Phase 3 Multicenter, Long-Term Extension Study Investigating the Long-Term Safety and Efficacy of Abrocitinib in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis (JADE EXTEND)

Ver Presentación